Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
University of Florida
Eli Lilly and Company
Hoffmann-La Roche
Tanabe Pharma America, Inc.
Turning Point Therapeutics, Inc.
PharmaMar
Cancer Research UK
Hutchmed
Institut Bergonié